Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Effects Toxics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04626466
What this trial is testing

Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic Irradiation

Who this might be right for
Prostate CarcinomaRectum CarcinomaAnal Canal Carcinoma+4 more
Institut de cancérologie Strasbourg Europe 100
Testing effectiveness (Phase 2)UnknownNCT06297369
What this trial is testing

Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients

Who this might be right for
Cisplatin Adverse ReactionCisplatin NephrotoxicityCisplatin Induced Peripheral Neuropathy+2 more
Ain Shams University 60
Not applicableNot Yet RecruitingNCT06986291
What this trial is testing

Radiation-induced Toxicity of the Heart

Who this might be right for
Non-small Cell Lung CancerEsophageal CancerBreast Cancer Female
Technische Universität Dresden 325
Not applicableUnknownNCT06077123
What this trial is testing

Telemonitoring Platforms and Chemotherapy-Associated Toxicity

Who this might be right for
CancerChemotherapeutic Agent Toxicity
Universidad Nacional Andres Bello 80
Large-scale testing (Phase 3)Study completedNCT00024427
What this trial is testing

Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganPancreatic Cancer
Wellstat Therapeutics 250
Not applicableLooking for participantsNCT06645093
What this trial is testing

Feasibility of Intermittent Fasting During Chemotherapy

Who this might be right for
LymphomaCancerFasting
University of Oslo 40
Not applicableStudy completedNCT04916392
What this trial is testing

Observation Study of the Pharmacokinetics of Adductor Canal Block

Who this might be right for
Toxicity, Drug
The University of Hong Kong 10
Not applicableStudy completedNCT01170299
What this trial is testing

Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer

Who this might be right for
Anal CancerBladder CancerCervical Cancer+6 more
Royal Marsden NHS Foundation Trust 177
Large-scale testing (Phase 3)Study completedNCT00296036
What this trial is testing

Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 137
Not applicableEnded earlyNCT05029154
What this trial is testing

Exercise Preconditioning in Ovarian Cancer

Who this might be right for
Ovarian Cancer
University of Virginia 8
Not applicableUnknownNCT04987801
What this trial is testing

Evaluation of Drug Overdose Poisoning Cases and Indications for ICU Admission

Who this might be right for
Drug Toxicity
Assiut University 100
Testing effectiveness (Phase 2)UnknownNCT04138381
What this trial is testing

Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)

Who this might be right for
Maximum Tolerated DoseGISTMetastatic Adult Soft Tissue Sarcoma+2 more
Grupo Espanol de Investigacion en Sarcomas 30
Very early researchStudy completedNCT02990013
What this trial is testing

AvenovaTM as a Sterile Skin Preparation Agent

Who this might be right for
Cleaning Product Causing Toxic Effect
University of Miami 21
Large-scale testing (Phase 3)Looking for participantsNCT03418961
What this trial is testing

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Who this might be right for
CardiotoxicityHER2/Neu PositiveMetastatic Malignant Neoplasm in the Brain+2 more
SWOG Cancer Research Network 491
Testing effectiveness (Phase 2)Looking for participantsNCT06679387
What this trial is testing

"The Effect of Memantine on the Prevention and Amelioration of Paclitaxel-induced Toxicity in Breast Cancer Patients"

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Ain Shams University 80
Not applicableUnknownNCT05063643
What this trial is testing

Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High Altitude

Who this might be right for
HER2-positive Breast CancerTargeted TherapyCardiac Toxicity+1 more
Affiliated Hospital of Qinghai University 132
Not applicableEnded earlyNCT01466504
What this trial is testing

Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin

Who this might be right for
Renal Cell CarcinomaHepatocellular CarcinomaColorectal Carcinoma
Dartmouth-Hitchcock Medical Center 4
Large-scale testing (Phase 3)Study completedNCT01918852
What this trial is testing

S-1 Versus Capecitabine in the First Line Treatment of MCC Patients.

Who this might be right for
Colorectal CancerMetastases
Dutch Colorectal Cancer Group 161
Large-scale testing (Phase 3)Ended earlyNCT00305643
What this trial is testing

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

Who this might be right for
Breast CancerColorectal CancerPain
M.D. Anderson Cancer Center 11
Large-scale testing (Phase 3)Not Yet RecruitingNCT07164534
What this trial is testing

A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to Reduce Late Radiotherapy Toxicity.

Who this might be right for
Uterine Cervical Neoplasm
Tata Memorial Hospital 316
Next Page